CBI's Forum on Effective Patent, IP and Trademark Strategies for the Bio/Pharmaceutical and Medical Device Industries

Obtain Critical Updates on Judicial Rulings, Legislative Reforms and USPTO Changes to Develop a Competitive Edge

WHEN

  • November 15 7:00 AM - November 16, 2007 6:45 PM

WHERE

  • Marriott Georgetown University Conference Center
  • Washington, DC

DESCRIPTION

There is no such thing as “business as usual” in the Intellectual Property profession. A number of proposed changes are pending in Congress and at the U.S. Patent and Trademark Office. Several important decisions evidencing a much more aggressive review of substantive patent law and other related issues have marked the judicial landscape. The ability to create a global brand continues to challenge, despite the obvious necessity to do so.

At this event, hear updates on the latest judicial rulings, legislative and USPTO reforms and network with peers to develop advanced strategies for encouraging and protecting innovation. Topics being discussed at this year’s event include:

  • Post-Grant Opposition
  • First-to-Invent to First-to-File – Adapting to the Proposed Change
  • Apportionment of Damages
  • KSR
  • Obvious-to-Try Standard
  • Licensing Negotiations
  • Gaining Name Approval with the FDA and EMEA
  • Determining Appropriate Trademarks while Considering Name-Related Medication Errors

Plus! Don’t Miss Two Government Keynote Addresses:

“Examination of the Patent Reform Act of 2007”
Matthew Sandgren, Counsel to Senator Orrin G. Hatch, U.S. Senate Committee on the Judiciary

“Changes in Patent Practice at the USPTO”
James A. Toupin, General Counsel, U.S. Patent and Trademark Office

Click here for more information and to register

For more information or to register, please contact the Center for Business Intelligence toll free by phone at 1-800-817-8601 or via e-mail at cbireg@cbinet.com.